The FDA authorizes Pfizer’s COVID-19 vaccine for children ages 5 to 11 – a pediatrician explains how the drug was tested for safety and efficacy
![](https://www.cobalis.com/wp-content/uploads/2021/11/solar-installation-2.jpg)
Elementary school children in the United States will soon have one more layer of protection to keep them safe from COVID-19. On Oct. 29, 2021, the Food and Drug Administration authorized emergency use of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11. The move came days after a tense and careful deliberation of […]